Related Experiment Videos
[Cancer and kidney transplantation]
P Montañés Medina1, F J Torrubia Romero, A C González Baena
1Servicio Universitario Virgen del Rocío, Sevilla.
Actas Urologicas Espanolas
|October 1, 1994
Summary
Transplanted patients face a higher risk of malignant tumors, especially skin and lip cancers, which are more aggressive. Careful screening and tumor history are crucial before transplantation.
Area of Science:
- Oncology
- Transplant Medicine
- Immunology
Context:
- Organ transplant recipients have an increased risk of de novo malignancies.
- Immunosuppressive therapy is a known risk factor for cancer development.
- Understanding cancer incidence and behavior in transplant patients is critical.
Purpose:
- To analyze cancer occurrence in transplant patients.
- To review literature on de novo and transferred malignancies post-transplant.
- To discuss the impact of immunosuppression on cancer risk and behavior.
Summary:
- De novo cancers, particularly skin and lip cancers (58%), are most frequent in transplant patients and exhibit more aggressive behavior.
- Renal cancer is the most common pre-existing malignancy (one-third of cases).
- Transferred tumors, though rare, pose significant clinical and legal challenges.
Impact:
- Highlights the need for vigilant cancer screening in transplant candidates and recipients.
- Emphasizes tailoring pre-transplant protocols based on individual tumor history.
- Informs clinical practice regarding immunosuppressive strategies and long-term surveillance for malignancies.